RCM
IART icon

Reynolds Capital Management’s Integra LifeSciences IART Stock Holding History

Reynolds Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,584
Closed -$209K – 163
2015
Q2 		$209K Buy
+7,584
New +$202K 0.2% 189

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Reynolds Capital Management's IART Position: Q3 2015 in Review

Reynolds Capital Management sold out of Integra LifeSciences (IART) in Q3 2015, closing a stake of 7,584 shares — an estimated $209K sold.

Reynolds Capital Management first reported a position in IART in Q2 2015 and held it in 1 quarter. The position peaked at $209K in Q2 2015. 189 funds tracked by Wall St. Rank hold IART as of Q3 2015.

  • Reynolds Capital Management reported no remaining Integra LifeSciences position as of Q3 2015 after selling out during the quarter.
  • Reynolds Capital Management sold 7,584 Integra LifeSciences shares in Q3 2015, an estimated $209K.
  • Reynolds Capital Management first reported a position in Integra LifeSciences in Q2 2015 and held it in 1 quarter.
  • Reynolds Capital Management's Integra LifeSciences position peaked at $209K in Q2 2015.
  • 189 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2015.

Based on Reynolds Capital Management's 13F filing for Q3 2015, filed 22 Oct 2015.